Global Pathogen Specific Kits Market, By Contaminant Type (E Coli, Salmonella, Listeria, Campylobacter, Pseudomonas, Cronobacter, Coliforms, Clostridium Perfringens, Legionella, and Others), Type (Products and Services), Food Type (Meat & Poultry, Dairy, Processed Food, Fruits & Vegetables, Cereals & Grains, Beverage, Water, Pharma Drugs, and Others), Consumer Type (Service Lab, Industry, and Governmental/Non-Profit Organization), Application (Food Safety, Diagnostics, Pathology, Clinical Research, Forensics, and Drug Delivery), End-Users (Diagnostic Centers, Pathology Laboratories, Hospitals, Blood Banks, and Pharmaceutical Companies), Distribution Channel (Direct Tender and Retail Sales) – Industry Trends and Forecast to 2030.
Pathogen Specific Kits Market Analysis and Size
Venipuncture, also known as invasive phlebotomy, is the most common invasive procedure in which blood is drawn from a vein with a needle for testing and diagnosis. Although relatively safe, some studies have suggested an increased risk of serious complications due to poor infection-control practices, which can result in pain, bruising, or even microbial infections at the puncture site. As a result, the risk of transmitting blood-borne pathogens to both patients and healthcare workers increases.
Data Bridge Market Research analyses that the pathogen-specific kits market was valued at USD 5.40 billion in 2022 and is expected to reach the value of USD 8.71 billion by the year 2030, at a CAGR of 5.30% during the forecast period. This indicates the market value. Product dominates the type segment of the pathogen specific kits market owing to the growing demand for increased demand for reliable testing. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pathogen Specific Kits Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, and Pricing in USD
|
|
Segments Covered
|
By Contaminant Type (E Coli, Salmonella, Listeria, Campylobacter, Pseudomonas, Cronobacter, Coliforms, Clostridium Perfringens, Legionella, and Others), Type (Products and Services), Food Type (Meat & Poultry, Dairy, Processed Food, Fruits & Vegetables, Cereals & Grains, Beverage, Water, Pharma Drugs, and Others), Consumer Type (Service Lab, Industry, and Governmental/Non-Profit Organization), Application (Food Safety, Diagnostics, Pathology, Clinical Research, Forensics, and Drug Delivery), End-Users (Diagnostic Centers, Pathology Laboratories, Hospitals, Blood Banks, and Pharmaceutical Companies), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America
|
|
Market Players Covered
|
Thermo Fisher Scientific (U.S.), Mabtech (Sweden), R&D Systems, Inc. (U.S.), PeproTech, Inc. (U.S.), PromoCell GmbH (Germany), Epitope Diagnostics, Inc. (U.S.), SBH Sciences (U.S.), and LifeSpan BioSciences, Inc (U.S.).
|
|
Market Opportunities
|
|
Market Definition
Pathogen testing is used to detect pathogenic organisms in manufacturing environments, ingredients, or finished products that may be harmful to the consumer. Pathogens are bacteria strains, viruses, fungi, or parasites that can cause illness in their host.
Global Pathogen Specific Kits Market Dynamics
Drivers
- Increasing Prevalence of Infectious Diseases
The rise in infectious diseases, such as viral, bacterial, and fungal infections, has created a growing need for accurate and rapid pathogen detection. Pathogen-specific kits enable quick identification of the causative agents, allowing for appropriate treatment and control measures. This in turn has carved the way for the growth of the market.
- Growing Research Activities
Increased R&D activities, rising acceptance of PCR & immunoassay-based technologies, rising awareness about food contamination, and rising awareness about the benefits of pathogen specific kits are expected to boost market growth.
. Opportunities
- Technological Advancements
Advances in molecular diagnostics, such as polymerase chain reaction (PCR) and next-generation sequencing (NGS), have improved the sensitivity, specificity, and speed of pathogen detection. Pathogen-specific kits leverage these technologies. It enables more accurate and efficient identification of pathogens and the rising number of partnerships and strategic collaborations between the public and private players about funding and application of new and improved technology. It is further creating lucrative market opportunities.
Restraints
- Lack of Awareness and Education
The adoption of pathogenic testing kits requires awareness and understanding among healthcare providers and the general population. Lack of awareness about the availability and benefits of these kits, and limited education on their proper usage and interpretation, are expected to restrain the market.
Challenges
- High Cost Associated with R&D
High costs associated with research and development proficiencies, limited infrastructural facilities, high costs associated with medicine, and a dearth of awareness in the backward economies are expected to obstruct market growth. Also, the lack of favorable reimbursement scenarios and technology penetration in the developing economies, the heavy customs duty imposed on medical devices, and the lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023-2030.
This pathogen specific kits market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In December 2021, Eurofins Technologies will launch its RapidScan ST5-W lateral flow reader, designed for field and in-process testing applications requiring qualitative to semi-quantitative test results
- In January 2021, Abbott announced that it had received CE Mark for two new applications of its Panbio COVID-19 Ag Rapid Test Device for the detection of the SARS-CoV-2 virus
Global Pathogen Specific Kits Market Scope
The pathogen specific kits market is segmented based on contaminant type, type, food type, consumer type, application, end-users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Contaminant Type
- E coli
- Salmonella
- Listeria
- Campylobacter
- Pseudomonas
- Cronobacter
- Coliforms
- Clostridium perfringens
- Legionell
- Others
Type
- Products
- Services
Food type
- Meat & poultry
- Dairy
- Processed food
- Fruits & vegetables
- Cereals & grains
- Beverage
- Water
- Pharma drugs
- Others
Consumer type
- Service lab
- Industry
- Governmental/non-profit organization
Application
- Food safety
- Diagnostics
- Pathology
- Clinical research
- Forensics
- Drug delivery
End use
- Diagnostic centers
- Pathology laboratories
- Hospitals
- Blood banks
- Pharmaceutical companies
Distribution channel
- Direct tender
- Retail sales
Pathogen Specific Kits Market Regional Analysis/Insights
The pathogen specific kits market is analysed and market size insights and trends are provided by country, contaminant type, type, food type, consumer type, application, end-users, and distribution channel as referenced above.
The countries covered in the global pathogen specific kits market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina, and rest of South America.
North America dominates the pathogen specific kits market because of the strong base of healthcare facilities, the strong presence of major players in the market, the increased prevalence of infectious diseases, and the rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2023 to 2030 due to the increased focus on infectious disease control, rising awareness and adoption of molecular diagnostics, growing research activities in the region, cost-effective solutions, large population pool, and growing demand for quality healthcare in the region.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends Porter's five forces analysis, and case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The pathogen specific kits market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the market, the impact of technology using lifeline curves, and changes in healthcare regulatory scenarios and their impact on the market. The data is available for the historic period 2010-2020.
Competitive Landscape and Pathogen Specific Kits Market Share Analysis
The pathogen specific kits market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the market.
Some of the major players operating in the pathogen specific kits market are:
- Thermo Fisher Scientific (U.S.)
- Mabtech (Sweden)
- R&D Systems, Inc. (U.S.)
- PeproTech, Inc. (U.S.)
- PromoCell GmbH (Germany)
- Epitope Diagnostics, Inc. (U.S.)
- SBH Sciences (U.S.)
- LifeSpan BioSciences, Inc (U.S.)
- PTS Diagnostics (U.S.)
- Sekisui Diagnostics (U.S.)
- Thermo Fisher Scientific (U.S.)
- bioMérieux S.A. (France)
SKU-